Development code · Small Molecule
SPG302
SPG302 is a development code for Tazbentetol, developed by Spinogenix, Inc..
- Status
- Phase 2 for Schizophrenia
- Developer
- Spinogenix, Inc.
Programs
- Tazbentetol for SchizophreniaPhase 2Active
Also known as
- SPG-302
- tazbentetol
- 2274723-90-7
- 2-[2-[2-[2-[4-(1,3-benzothiazol-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethanol